The research team found that there was an upregulation in IL-10, Osteopontin, MMP14, VEGF, TGF β, and CCL18 in samples containing both human stem cell derived microglial cells with human glioma cells, as opposed to samples containing human glioma cells alone (40). The gene discussed is IL10; the disease is central nervous system cancer.